Cart
sales@molnova.com
Indantadol HCl
CAS No. 202914-18-9
Indantadol HCl( —— )
Catalog No. M34285 CAS No. 202914-18-9
Indantadol HCl (CHF-3381) is a NMDA antagonist and nonselective MAO inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 409 | In Stock |
|
| 10MG | 604 | In Stock |
|
| 25MG | 938 | In Stock |
|
| 50MG | 1265 | In Stock |
|
| 100MG | 1702 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3422 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIndantadol HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionIndantadol HCl (CHF-3381) is a NMDA antagonist and nonselective MAO inhibitor.
-
DescriptionIndantadol HCl (CHF-3381) is a NMDA antagonist and nonselective MAO inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetNMDAR
-
RecptorNMDAR | MAO
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number202914-18-9
-
Formula Weight226.7
-
Molecular FormulaC11H15ClN2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.O=C(N)CNC1CC=2C=CC=CC2C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CIQ
CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit. EC50 value: 2.7 μM for NR2C and 2.8 μM for NR2D.
-
TCS 46b
TCS 46b is a NR1A/NR2B NMDA receptor antagonist with oral activity.
-
GNE-8324
GNE-8324 is a GluN2A selective positive allosteric modulator that selectively enhances NMDAR-mediated synaptic responses in inhibitory, but not excitatory, neurons.
